Method for producing culture product and method for recovering cells
By culturing adherent cells on a larger soluble carrier and applying a denaturation treatment to detach and separate based on size, the method addresses the challenge of lysis residue contamination, achieving high-purity cell cultures.
Patent Information
- Application Number
- JP2023511346
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-03-31
- Filing Date
- 2022-03-29
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2042-03-29
AI Technical Summary
Existing methods for producing cell cultures using soluble culture carriers result in significant contamination from lysis residues that are similar in size to or smaller than the cells, making it difficult to achieve high purity and purity of adherent cells.
The method involves contacting adherent cells with a soluble culture carrier larger than the cells, culturing them on its surface, and applying a denaturation treatment to detach the cells while maintaining the carrier's size, allowing separation based on size differences using a separation device.
This approach achieves a culture with minimal contamination and high purity of adherent cells by effectively separating and recovering cells from the denatured soluble culture carrier, reducing impurities to a low content.
Smart Images

Figure 0007589801000002 
Figure 0007589801000003 
Figure 0007589801000001
Abstract
Description
[Technical field]
[0001] The present disclosure relates to methods for producing cultures, cell harvesting methods, kits and cell-containing compositions. [Background technology]
[0002] Cell culture is broadly classified into plate culture, in which adherent cells are grown in a monolayer on a flat culture carrier, and suspension culture, in which adherent cells are attached to the surface of a mainly particulate culture carrier and cultured in a state in which the cells are suspended in the culture system as a complex of the adherent cells and the culture carrier. In suspension culture, the culture carrier functions as a scaffold for cell growth to efficiently increase the number of cells, and after cell culture, the cells are peeled off from the culture carrier using an enzyme, a chelating agent, or the like, and collected. Culture carriers that can be used for suspension culture include soluble and insoluble ones, and when a soluble culture carrier is used, the culture carrier is dissolved after cell culture, and only the cells are collected using a filter or the like. Such suspension culture is preferably used for mass cell culture. Soluble culture carriers have established dissolution means suited to their constituent components, and can be dissolved well after cell culture according to a protocol.
[0003] For example, JP 2016-523086 A discloses a cell culture article comprising a substrate containing a polygalacturonic acid compound such as pectinic acid and an adhesive polymer on the substrate surface, and proposes using pectinase and a chelating agent to dissolve the culture carrier and easily harvest cells. Summary of the Invention [Problem to be solved by the invention]
[0004] When cells obtained in large quantities using the culture carrier are used, for example, as a cell preparation, it is necessary to remove as many impurities other than cells as possible. However, when a soluble culture carrier is dissolved well according to an established protocol, lysis residues are generated in the cell suspension. Since most of the lysis residues are the same size as or smaller than the size of the cells, it is difficult to completely avoid the inclusion of lysis residues even if one tries to recover only the cells from the cell suspension. The present disclosure provides a method for producing a culture having low impurity contamination and high purity of adherent cells, a cell recovery method, a kit suitable for these methods, and a cell-containing composition having high purity of adherent cells. [Means for solving the problem]
[0005] Each embodiment of the present disclosure is as follows. [1] A method for producing a culture, comprising: bringing adherent cells into contact with a soluble cultivation support larger than the size of the adherent cells, thereby disposing the adherent cells on the surface of the soluble cultivation support; culturing the adherent cells disposed on the surface of the soluble cultivation support in suspension in a medium; subjecting the soluble cultivation support to a denaturation treatment for denaturing at least a portion of the surface thereof in order to detach the adherent cells in the suspension culture from the surface of the soluble cultivation support; and, after the denaturation treatment, separating and recovering the adherent cells from the denatured soluble cultivation support larger than the size of the adherent cells based on the difference in size.
[0006] [2] The method for producing a culture described in [1], wherein the soluble cultivation support comprises a polysaccharide, a protein, or a combination thereof. [3] The method for producing a culture described in [1] or [2], wherein the soluble culture support comprises at least one selected from the group consisting of dextran, cellulose, collagen, gelatin, polygalacturonic acid, alginic acid, and derivatives thereof. [4] The method for producing a culture described in any one of [1] to [3], wherein the soluble cultivation support is porous.
[0007] [5] The method for producing a culture according to any one of [1] to [4], wherein the denaturation treatment includes denaturing the soluble cultivation support with a surface denaturing agent. [6] The method for producing a culture described in any one of [1] to [5], wherein the adherent cells and the modified soluble cultivation support are separated using a separation device. [7] The separation device has a pore size of 20 to 50 μm. manufacturing method. [8] The method for producing a culture according to any one of [1] to [7], wherein the modified soluble cultivation support has a minimum diameter exceeding 50 μm.
[0008] [9] A cell recovery method comprising: preparing a cell suspension containing a cell complex comprising adherent cells and a soluble culture carrier larger than the size of the adherent cells, the adherent cells being arranged on the surface of the soluble culture carrier; subjecting the cell complex in the cell suspension to a denaturation treatment for denaturing at least a portion of the surface of the soluble culture carrier in order to detach the adherent cells from the surface of the soluble culture carrier; and separating and recovering the adherent cells in the cell suspension from the denatured soluble culture carrier larger than the size of the adherent cells based on the difference in size.
[10] Soluble Culture carrier and a method for producing a culture according to any one of [1] to [8] or a method for recovering cells according to [9], Culture carrier and instructions for use in using the kit.
[11] Soluble Culture carrier and instructions for use in using the surface modifying agent in the culture production method described in any one of [1] to [8] or the cell recovery method described in [9].
[12] The content of dissolved residues of a soluble culture carrier containing adherent cells and having a size of 20 μm or less is 1×10 cells 4 A cell-containing composition having 30 or fewer cells per cell.
[13] Soluble Culture carrierUse of the method for producing a culture according to any one of [1] to [8], the method for recovering cells according to [9], or the kit according to
[10] .
[14] Soluble Culture carrier Use of a surface denaturing agent for denaturing a culture medium described in any one of [1] to [8], in the cell recovery method described in [9], or in the kit described in
[10] . Effect of the Invention
[0009] According to the present disclosure, it is possible to provide a method for producing a culture having low impurity contamination and high purity of adherent cells, a cell recovery method, a kit suitable for these methods, and a cell-containing composition having high purity of adherent cells. [Brief description of the drawings]
[0010] [Figure 1] 1 shows phase contrast microscope images of one visual field after denaturation treatment of the cell suspensions prepared in the examples and comparative examples. [Diagram 2] 13 is a phase contrast microscope image of one field of view after denaturation treatment and pipetting of the cell suspension prepared in the comparative example. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0011] In this specification, a numerical range indicated using "~" indicates a range including the numerical values described before and after "~" as the minimum and maximum values, respectively. In the numerical ranges described in stages in this specification, the upper limit or lower limit of a numerical range of a certain stage can be arbitrarily combined with the upper limit or lower limit of a numerical range of another stage. In the numerical ranges described in this specification, the upper limit or lower limit of the numerical range may be replaced with a value shown in the examples. In this specification, the content of each component in the composition means the total amount of the multiple substances present in the composition when multiple substances corresponding to each component are present in the composition, unless otherwise specified. In this specification, the term "process" includes not only an independent process, but also a process that cannot be clearly distinguished from other processes as long as the intended effect of the process is achieved. Unless otherwise specified, an element indicates a single or multiple elements.
[0012] Hereinafter, the embodiments of the present disclosure will be described. The present invention is not limited to the examples in the following embodiments. The terms and expressions in the following description are not limited to the specific examples in the following examples. [Production method of culture] A method for producing a culture according to an embodiment of the present disclosure includes contacting adherent cells with a soluble cultivation support larger than the size of the adherent cells to place the adherent cells on the surface of the soluble cultivation support, culturing the adherent cells placed on the surface of the soluble cultivation support in suspension in a medium, performing a denaturation treatment on the soluble cultivation support to denature at least a portion of the surface in order to detach the adherent cells in suspension culture from the surface of the soluble cultivation support, and, after the denaturation treatment, separating and recovering the adherent cells from the denatured soluble cultivation support larger than the size of the adherent cells based on the difference in size.
[0013] According to this method for producing a culture, a culture with little impurity contamination and high purity of adhesive cells can be obtained. That is, according to this method for producing a culture, in order to detach adhesive cells from a soluble culture carrier having adhesive cells on its surface, a denaturation treatment is performed to denature at least a part of the surface, rather than dissolving the entire soluble culture carrier. It is believed that the adhesive cells use the surface of the soluble culture carrier as a scaffold for adhesion, and that the denaturation treatment causes the adhesive cells to lose the scaffold for adhesion and detach from the surface of the culture carrier, but this theory is not limited to this. In addition, since the denaturation treatment only modifies the surface of the soluble culture carrier, a large amount of dissolved residue that occurs when the entire soluble culture carrier is dissolved is not generated, and the size of the denatured soluble culture carrier obtained after the denaturation treatment is not smaller than the size of the adhesive cells. As a result, the adhesive cells can be accurately and easily separated and recovered from the denatured soluble culture carrier based on the difference in size between the adhesive cells and the denatured soluble culture carrier. The resulting culture preferably contains adherent cells, does not contain soluble culture carriers, and has an extremely low content of residues derived from the soluble culture carriers. More specifically, the resulting culture preferably has an extremely low content of residues, such as undissolved residues that are generated when the soluble culture carriers are dissolved, that are equal to or smaller in size than the cells.
[0014] In the following description, the cell complex means a complex containing adherent cells and a soluble culture carrier, and the adherent cells are arranged on the surface of the soluble culture carrier. The cell suspension means a liquid containing adherent cells.
[0015] The method for producing the culture can include contacting the adherent cells with a soluble cultivation support that is larger than the size of the adherent cells, and arranging the adherent cells on the surface of the soluble cultivation support.
[0016] The adhesive cells are preferably cells that can be supported on the surface of a soluble culture carrier and whose growth can be promoted when placed on the surface of the soluble culture carrier. The adhesive cells can be combined with an aqueous medium to form a cell suspension. The aqueous medium that forms the cell suspension can be a culture medium, physiological saline, a phosphate buffer solution, or the like. The cells are preferably cells derived from animals, more preferably cells derived from mammals. Examples of mammals include humans, monkeys, chimpanzees, cows, pigs, horses, sheep, goats, rabbits, rats, mice, guinea pigs, dogs, and cats. The tissues from which the cells are derived are not particularly limited, and may be, for example, skin, liver, kidneys, muscles, bones, blood vessels, blood, and nerve tissues. The cells may be primary cultured cells, cultured cell lines, recombinant cultured cell lines, and the like.
[0017] Examples of stem cells include somatic stem cells such as mesenchymal stem cells, hematopoietic stem cells, neural stem cells, bone marrow stem cells, germline stem cells, and dental pulp stem cells, and are preferably mesenchymal stem cells. Mesenchymal stem cells are present in various tissues of an individual and broadly refer to somatic stem cells that can differentiate into all or some of the mesenchymal cells such as osteoblasts, chondrocytes, and adipocytes. Examples of mesenchymal stem cells include bone marrow-derived mesenchymal stem cells, umbilical cord-derived mesenchymal stem cells, and adipose tissue-derived mesenchymal stem cells. As stem cells, for example, pluripotent stem cells such as induced pluripotent stem cells (iPS cells), embryonic stem cells (ES cells), embryonic germ stem cells (EG cells), pluripotent germ stem cells (mGS cells), embryonic tumor cells (EC cells), and Muse cells may be used.
[0018] The cells may be, for example, differentiated cells such as endothelial cells, epidermal cells, epithelial cells, cardiac muscle cells, myoblasts, nerve cells, bone cells, osteoblasts, fibroblasts, adipocytes, hepatic cells, kidney cells, pancreatic cells, adrenal cells, periodontal ligament cells, gingival cells, periosteal cells, skin cells, dendritic cells, macrophages, and lymphocytes; or precursor cells which are at a stage prior to the transformation of stem cells into these differentiated cells. The above-mentioned cells can be used alone or in combination of two or more kinds.
[0019] The soluble culture carrier means a culture carrier made of a material that can be decomposed by means of an enzyme, heat, etc. The soluble culture carrier is capable of supporting adhesive cells on its surface, and the adhesive cells are arranged on the surface to form a cell complex containing the soluble culture carrier and the adhesive cells. In addition, it is preferable that the surface of the soluble culture carrier is modified by a denaturing treatment, so that the effect of supporting the adhesive cells is weakened.
[0020] The soluble culture carrier can be used without any particular limitation as long as the surface of the carrier can be used as a scaffold for the growth of adhesive cells. The soluble culture carrier can contain, for example, polysaccharides, proteins, polypeptides, or combinations thereof, preferably polysaccharides, proteins, or combinations thereof, more preferably polysaccharides. The soluble culture carrier can be either a natural polymer or a synthetic polymer. Examples of polysaccharides include polygalacturonic acids such as pectin and pectic acid; alginic acid, cellulose, dextran, agarose, chitosan, glycosaminoglycan, and derivatives thereof. These may have a crosslinked structure, such as crosslinked cellulose, crosslinked dextran, crosslinked agarose, and crosslinked chitosan. Among these, polygalacturonic acid, polygalacturonic acid ester, alginic acid, alginic acid ester, cellulose, crosslinked cellulose, dextran, crosslinked dextran, or combinations thereof are preferred. Examples of proteins include collagen and gelatin. The soluble culture carrier preferably contains at least one selected from the group consisting of dextran, cellulose, collagen, gelatin, polygalacturonic acid, alginic acid, and derivatives thereof. The cellulose and dextran may be cross-linked or non-cross-linked. Among them, it is preferable to contain dextran, cross-linked dextran, or a combination thereof, and more preferably to contain cross-linked dextran.
[0021] A cationic functional group may be introduced on the surface of the soluble culture carrier in order to improve the supportability (adhesiveness) of the adhesive cell. Examples of the cationic functional group include an amino group having a substituent, a primary amino group, and a quaternary ammonium group. Examples of the amino group having a substituent include an amino group having an alkyl group having 1 to 10 carbon atoms, preferably 1 to 4 carbon atoms, and may be either a monoalkylamino group or a dialkylamino group, and specific examples thereof include a methylamino group, a dimethylamino group, an ethylamino group, a diethylamino group, a methylethylamino group, a propylamino group, a dipropylamino group, a butylamino group, and a dibutylamino group. The cationic functional group may be a functional group having a substituted or unsubstituted amino group, and examples thereof include an aminoalkyl group, and specific examples thereof include an aminoethyl group, an aminopropyl group, a methylaminoethyl group, a dimethylaminoethyl group, an ethylaminoethyl group, and a diethylaminoethyl group. These cationic functional groups may be introduced on the surface of the soluble culture carrier alone or in combination of two or more kinds. In addition, from the viewpoint of promoting the support of adhesive cells, a cell adhesive polymer may be arranged on the surface of the soluble culture carrier to constitute a part or the whole of the surface of the soluble culture carrier. Examples of the cell adhesive polymer include collagen, gelatin, alginic acid or its salt, Matrigel (trademark) (BD Biosciences), hyaluronic acid, laminin, fibronectin, vitronectin, elastin, heparan sulfate, dextran, dextran sulfate, chondroitin sulfate, etc. Among them, cell adhesive polypeptides such as collagen, gelatin, laminin, fibronectin, and vitronectin are preferred. Specific examples of the soluble culture carrier include dextran or crosslinked dextran having a dialkylamino group, and dextran or crosslinked dextran coated with collagen or denatured collagen.
[0022] The shape of the soluble culture carrier is not particularly limited, and may be any shape capable of supporting adhesive cells, such as a sphere, flattened shape, cylindrical shape, striped shape, prismatic shape, etc. The soluble culture carrier preferably includes a spherical soluble culture carrier. The soluble culture carrier may be a porous culture carrier having pores on the surface, inside, or both, or may be a solid culture carrier having no pores inside or both inside and surface. By using a porous culture carrier as the soluble culture carrier, the surface area of the soluble culture carrier can be increased, and the number of adherent cells supported on the surface of the soluble culture carrier can be increased.
[0023] Examples of the soluble culture support according to this embodiment include Cytiva's Cytodex (registered trademark, hereinafter omitted) series, Cytopore series Sephadex (registered trademark, hereinafter omitted) series, and the like.
[0024] The soluble culture carrier can have a size larger than that of the adherent cells. The size of the soluble culture carrier can be confirmed by passing a cell suspension containing the adherent cells and the soluble culture carrier through a filter having a predetermined pore size. The pore size of the filter that can be used for this confirmation may be in a range larger than the size of the adherent cells and smaller than that of the soluble culture carrier. More specifically, the size of the adherent cells varies depending on the type of the adherent cells, but may be, for example, 1 to 50 μm, 10 to 30 μm, 10 to 20 μm, or 10 to 18 μm. Furthermore, the adherent cells may be of a size that allows them to pass through a filter having a pore size of 10 μm or more and 50 μm or less, 30 μm or less, 20 μm or less, or 18 μm or less.
[0025] Before the denaturation treatment, the average particle size (D50) of the soluble cultivation carrier may be, for example, 40 to 1,000 μm, 50 to 500 μm, 100 to 250 μm, or 100 to 200 μm. Within this range, the size of the soluble cultivation carrier before the denaturation treatment is larger than that of the adhesive cells, and a plurality of adhesive cells can be supported on the surface of the soluble cultivation carrier, which can contribute to promoting cell proliferation. Furthermore, since the size of the soluble cultivation carrier before the denaturation treatment is larger than that of the adhesive cells within this range, the size of the soluble cultivation carrier is easily maintained larger than that of the adhesive cells even after the denaturation treatment, and the adhesive cells can be easily separated from the denatured soluble cultivation carrier based on the size of the cells. In the present disclosure, the average particle size of the soluble cultivation carrier is a value measured as a volume-based median size (D50) in physiological saline or culture medium. The average particle size of the soluble cultivation carrier can be measured by a laser diffraction scattering type particle size distribution measuring device. However, when the soluble cultivation carrier is a commercially available product, the product information attached to the product can be referred to.
[0026] Before the denaturation treatment, the size of the soluble cultivation support is preferably more than 50 μm in minimum diameter. Before the denaturation treatment, the size of the soluble cultivation support may be, for example, more than 50 μm, 80 μm or more, 100 μm or more, 150 μm or more, or 170 μm or more in minimum diameter. By having the size of the soluble cultivation support in this range before the denaturation treatment, it is easy to maintain the difference in size between the denatured soluble cultivation support and the adhesive cells after the denaturation treatment, and this makes it easy to separate and recover the adhesive cells from the denatured soluble cultivation support.
[0027] In the present disclosure, the minimum diameter of the soluble cultivation carrier can mean a value obtained by the following measurement method or a value of D5. The minimum diameter of the soluble cultivation carrier can be confirmed by observing a plurality of locations, for example, five fields of view, with a phase contrast microscope and referring to a measure or a scale bar attached to the microscope. In this case, the soluble cultivation carrier may be fluorescently colored. In addition, the minimum diameter of the soluble cultivation carrier may be simply confirmed using a filter having a pore size of 50 μm. In the present disclosure, the D5 of the soluble cultivation carrier is the particle diameter when the volume-based particle size distribution in physiological saline or culture medium is measured and the cumulative volume from the side with the smaller particle diameter is 5%. The particle size distribution of the soluble cultivation carrier can be measured by a laser diffraction scattering type particle size distribution measuring device. However, when the soluble cultivation carrier is a commercially available product, the product information attached to the product can be referred to. The average particle size (D50), D5, and minimum diameter of the soluble cultivation support can be determined by the same procedure before and after the denaturation treatment.
[0028] A method for contacting the adhesive cells with the soluble culture carrier can be, for example, to add the soluble culture carrier and the adhesive cells to the medium in the cell culture vessel before, at, or after the start of the culture. There is no particular restriction on the order of addition. There is no particular restriction on the amount of the soluble culture carrier and the adhesive cells added to the medium, and the amount may be appropriately selected depending on the scale of the cell culture, the equipment, etc.
[0029] The method for producing the culture can include subjecting adherent cells arranged on the surface of a soluble cultivation support to suspension cultivation in a medium. The adhesive cells arranged on the surface of the soluble culture carrier may be the above-mentioned adhesive cells and the soluble culture carrier contacted in the medium. That is, when the adhesive cells and the soluble culture carrier are put into the medium, the suspension culture may be started from that state, or the above-mentioned adhesive cells and the soluble culture carrier contacted in a medium other than the medium, such as a buffer solution, may be mixed with the medium, and the suspension culture may be started.
[0030] As the proliferation of the adherent cells progresses with the passage of time in the suspension culture in the culture vessel, a cell complex is formed, which is a complex of the adherent cells and the soluble culture carrier, and the adherent cells proliferate on the soluble culture carrier of the cell complex. Note that the cell suspension may contain not only the cell complex, but also cell masses (aggregates) formed by the aggregation of multiple cells, culture carriers to which cells are not adhered, etc. Examples of culture carriers to which cells are not adhered include additional soluble culture carriers that are added during suspension culture.
[0031] The seeding density of adherent cells at the start of culture varies depending on the cell type, culture conditions, etc., but is, for example, 5 × 10 2 ~2×10 5 cells / mL, 1×10 3 ~1×10 5 cells / mL, or 1 x 10 3 ~5×10 4 The concentration of the soluble cultivation support in the cell suspension at the start of cultivation can be, for example, 0.05 to 50 g / L, 0.1 to 10 g / L, or 0.3 to 5 g / L. When the soluble cultivation support is porous, the surface area of the soluble cultivation support can be 0.1 to 30 cm 2 / mL, 0.5-20cm 2 / mL, 1-10cm 2 / mL or 3-8cm 2 The concentration of the soluble cultivation carrier can be adjusted within the range of 100 / mL. The adhesive cells and the soluble cultivation carrier are used in appropriate combination within this range.
[0032] The medium used for culturing the adherent cells preferably contains inorganic salts, amino acids, sugars, and water. The medium may further contain any components such as serum, vitamins, hormones, antibiotics, growth factors, and adhesion factors. As the medium, a medium known as a basal medium for cell culture can be used. That is, as the medium, any medium known to be used for culturing selected cells can be used without any particular limitation. Examples of media include, but are not limited to, DMEM (Dulbecco's modified Eagle's medium), MEM (Eagle's minimum essential medium), αMEM medium (Eagle's minimum essential medium α modified type), GMEM (Glasgow's minimum essential medium), IMDM (Iscove's modified Dulbecco's medium), Ham's F12 (nutrient mixture F-12 Ham), RPMI-1640 (RPMI-1640 medium), McCoy's 5A (McCoy's 5A medium), MSC growth medium 2 (Promocell), Prime XV XSFM (Irvine Scientific), etc. These may be used alone or in combination of two or more.
[0033] When serum is added to the medium, for example, fetal bovine serum (FBS), horse serum, human serum, and the like can be used. The medium used for the culture may be one that does not contain xenogeneic components. The xenogeneic component-free medium may contain a serum replacement additive (e.g., Knockout Serum Replacement (KSR) (Invitrogen), Chemically-defined Lipid concentrated (Gibco), Glutamax (Gibco)) instead of animal-derived serum. Other serum-free media that can be used include Essential 8 (Thermo Fisher), mTeSR1 (STEMCELL Technologies), StemFit series (Takara Bio Inc.), and StemFlex (Thermo Fisher Scientific).
[0034] Additives may be added to the medium as necessary, for example, vitamins such as vitamin A, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, and vitamin D; coenzymes such as folic acid; amino acids such as glycine, alanine, arginine, asparagine, glutamine, isoleucine, and leucine; sugars or organic acids as carbon sources such as lactic acid; growth factors such as EGF, FGF, PFGF, and TGF-β; interleukins such as IL-1 and IL-6; cytokines such as TNF-α, TNF-β, and leptin; metal transporters such as transferrin; metal ions such as iron ions, selenium ions, and zinc ions; SH reagents such as β-mercaptoethanol and glutathione; and proteins such as albumin.
[0035] The cell culture method is not particularly limited, and a method suitable for each cell may be used. The temperature of the cell culture may be, for example, within the range of 20 to 45°C or 30 to 40°C, preferably 36 to 37°C, in terms of the temperature of the cell suspension. The pH of the cell culture may be, for example, within the range of 6.2 to 7.7, preferably 7.4, in terms of the pH of the cell suspension. The CO2 concentration of the cell culture may be, for example, within the range of 1 to 20% by volume, 4 to 10% by volume, preferably 5 to 7% by volume, in terms of the CO2 concentration of the cell suspension. In the case of mammalian cell culture, a temperature of 37°C and a carbon dioxide concentration of 5% (v / v) are generally used.
[0036] The suspension culture may be a dynamic suspension culture in which rocking such as stirring or shaking is performed continuously or intermittently, or a static suspension culture without rocking. Culture vessels suitable for rocking are not particularly limited, but examples thereof include flasks, bioreactors, tanks, culture bags, etc. The rocking method is not particularly limited, and a method appropriate for the selected culture vessel can be applied. Rocking methods include, for example, stirring, shaking, tilting, or a combination thereof. During the suspension culture, the medium can be appropriately replaced as necessary. The medium may be replaced in its entirety, or may be partially replaced, for example, half of the medium. The suspension culture may be scaled up by appropriately adding medium to increase the volume of the cell suspension depending on the state of growth of the adherent cells. Examples of the scale-up of the culture include, but are not limited to, sequential expansion to 0.3 L or more, 2 L or more, 4 L or more, and 10 L or more.
[0037] The method for producing a culture may include subjecting the soluble cultivation support to a denaturing treatment for denaturing at least a portion of the surface thereof in order to detach adherent cells in suspension culture from the surface of the soluble cultivation support.
[0038] In the denaturation treatment, at least a part of the surface of the soluble culture carrier having the adhesive cells on the surface may be denatured, and the entire surface of the soluble culture carrier may be denatured, whereby the ability of the soluble culture carrier to support the adhesive cells is reduced, and the adhesive cells can be detached from the surface of the culture carrier.
[0039] The denaturation treatment may be any treatment that changes the properties of the surface of the soluble culture carrier, for example, impairs the function as a scaffold for cells, and enables adhesive cells to detach, and may be appropriately selected depending on the type, size, shape, etc. of the soluble culture carrier. The denaturation treatment may be performed by temperature change, etc., or may be performed using a surface denaturing agent. When the soluble culture carrier is made of a temperature-sensitive material, the adhesive cells can be detached by changing the temperature to a degree that changes the properties of the carrier as a scaffold for the cells. The temperature can be appropriately adjusted depending on the material that constitutes the soluble culture carrier.
[0040] The surface modifier may be a component capable of modifying the properties of the surface of the soluble culture carrier as a scaffold for cells. By using such a surface modifier, for example, the surface of the soluble culture carrier is modified by the surface modifier to an extent that the size of the soluble culture carrier is not significantly reduced and the function of the surface of the soluble culture carrier as a scaffold is reduced. This makes it easier for adhesive cells to detach from the surface of the soluble culture carrier.
[0041] The size of the soluble cultivation carrier after the denaturation treatment is larger than that of the adhesive cells, and may be 1.5 times or more, 2 times or more, 3 times or more, 5 times or more, 8 times or more, or 10 times or more than that of the adhesive cells from the viewpoint of separation using a separation device such as a filter. The size of the soluble cultivation carrier after the denaturation treatment may be, for example, 50% or more, 80% or more, or 90% or more compared to the size of the soluble cultivation carrier before the denaturation treatment. The following methods can be used to confirm the comparison of the size of the soluble cultivation carrier before and after the denaturation treatment. After the denaturation treatment, observation or images are taken using a phase contrast microscope, and the size of the denatured soluble cultivation carrier is confirmed using a measure or scale bar attached to the microscope. The average of the minimum diameters of 30 to 40 denatured soluble cultivation carriers per field is taken, and this is carried out for five fields, and the average is calculated to determine the ratio when the minimum diameter of the soluble cultivation carrier before the denaturation treatment is taken as 100%.
[0042] The average particle size (D50) of the modified soluble cultivation support may be, for example, 40 to 1,000 μm, 50 to 500 μm, 100 to 250 μm, or 100 to 200 μm. Within this range, the adhesive cells can be more easily separated from the modified soluble cultivation support based on the size of the cells.
[0043] The modified soluble cultivation carrier preferably has a minimum diameter of more than 50 μm. The modified soluble cultivation carrier may have a minimum diameter of, for example, more than 50 μm, 80 μm or more, 100 μm or more, 150 μm or more, or 170 μm or more. When the modified soluble cultivation carrier has a minimum diameter within this range, the difference in size between the modified soluble cultivation carrier and the adherent cells is sufficient for separation and recovery in the subsequent separation and recovery step, making it easy to separate and recover the cells. The average particle size (D50), D5, and minimum diameter of the modified soluble cultivation carrier can be determined by the same procedure as that for the soluble cultivation carrier before the above-mentioned modification treatment. In addition, in the measurement of the modified soluble cultivation carrier, a sample from which cells have been removed through separation and recovery from a modified cell suspension may be used.
[0044] The conditions for modifying the surface of a soluble cultivation support with a surface modifying agent vary depending on the type of surface modifying agent used and the state of the cells, but a person skilled in the art can appropriately set the conditions by relaxing the concentration, treatment time, etc. compared to the conditions for completely dissolving the soluble cultivation support.
[0045] The surface modifier can be selected from known dissolving agents or decomposing agents depending on the type of soluble culture carrier used. Specific examples of the surface modifier include enzymes, chelating agents, acids, alkalis, etc. Enzymes include saccharide decomposing enzymes and proteolytic enzymes. Examples of saccharide decomposing enzymes include dextranase, pectinase, polygalacturonase, cellulase, alginate lyase, agarase, chitosanase, etc. Proteolytic enzymes include collagenase and trypsin, etc. Chelating agents include ethylenediaminetetraacetic acid (EDTA), ethylenediamine-N,N'-disuccinic acid (EDDS), etc. For example, when the soluble cultivation support contains an ester compound, the surface of the soluble cultivation support can be hydrolyzed using an acid or an alkali as a catalyst to perform a modification treatment. Known acids and alkalis can be used for this purpose. The above surface modifying agents may be used alone or in combination of two or more kinds.
[0046] The surface modifier may be appropriately selected according to the type of soluble culture carrier. For example, a combination of a soluble culture carrier containing dextran or crosslinked dextran and dextranase, a combination of a soluble culture carrier containing cellulose or crosslinked cellulose and cellulase, a combination of a soluble culture carrier containing polygalacturonic acid such as pectin and pectinase or polygalacturonase, a combination of a soluble culture carrier containing collagen and collagenase or trypsin, a combination of a soluble culture carrier containing gelatin and trypsin, a combination of a soluble culture carrier containing alginic acid and alginate lyase, a combination of a soluble culture carrier having a cell adhesive polypeptide on the surface and trypsin, etc. can be mentioned. Since the hydrolysis of ester compounds such as polygalacturonic acid esters and alginic acid esters can be promoted by using an acid or alkali as a catalyst to modify the surface, an acid or alkali can also be used as a surface modifier.
[0047] The conditions of the denaturation treatment under which the size of the soluble culture carrier becomes larger than that of the cells after the denaturation treatment may be adjusted, for example, by adjusting the type of surface denaturant, the concentration of the surface denaturant, the denaturation treatment temperature, the denaturation treatment time, etc. For example, the concentration of the surface denaturant in the cell suspension may be lower than the concentration required for complete dissolution, the denaturation treatment time may be shorter than the time required for complete dissolution, the denaturation treatment temperature may be lower or higher than the temperature required for complete dissolution, or a combination of these may be used. The denaturation treatment using the surface denaturant may be performed under milder conditions than those required for complete dissolution of the soluble culture carrier, thereby allowing the denaturation treatment to be performed without applying excessive stress to the adherent cells.
[0048] Another example of the surface denaturing agent is a pH adjuster when the soluble cultivation support can be surface-denatured by pH. The pH adjuster may be an acid or an alkali. When the denaturing treatment is performed using a pH adjuster, the treatment can be performed under milder conditions than those for completely dissolving the soluble cultivation support.
[0049] Simultaneously with or separately from the surface modification treatment, a cell detachment treatment can be performed to promote the detachment of adhesive cells from the surface of the soluble culture carrier. The cell detachment agent used in the cell detachment treatment can be any known cell detachment agent without any particular limitation, for example, protease, chelating agent, etc., specifically trypsin, EDTA (ethylenediaminetetraacetic acid), etc., and combinations thereof, for example, TrypLE (Thermo Fisher Scientific), etc.
[0050] After the denaturation treatment, the cell suspension may be pipetted before the cells are separated and collected. By pipetting, the soluble culture carriers and the adherent cells detached from the soluble culture carriers are dispersed, so that the cells can be easily separated and collected in the subsequent step.
[0051] The method for producing the culture may include, after the denaturation treatment, separating and recovering the adherent cells from the denatured soluble cultivation support, which is larger than the size of the adherent cells, based on the difference in size. The separation and recovery of the adherent cells is carried out based on the difference in size between the adherent cells and the denatured soluble culture carriers, and therefore the adherent cells can be separated and recovered easily and accurately.
[0052] As described above, the denaturation treatment modifies the surface of the soluble cultivation support, and does not completely dissolve the soluble cultivation support, so that the denatured cultivation support tends to maintain its size within the above-mentioned range after the denaturation treatment. As a result, the denatured cultivation support can maintain a size larger than that of the cells.
[0053] Since the size of the modified soluble culture carrier is larger than that of the adhesive cells, the adhesive cells can be separated and collected from the modified soluble culture carrier based on the difference in size. For example, a separation device such as a filter can be used for the separation. The shape of the pores of the separation device may be any shape as long as it can filter the adherent cells and separate the adherent cells from the modified soluble cultivation carrier. Examples of the shape of the pores of the separation device include a circle, an ellipse, a rectangle, a polygon, etc.
[0054] The pore size of the separation device may be appropriately selected in consideration of the size of the adherent cells, the size of the soluble cultivation support, etc. For example, the pore size of the separation device is preferably larger than the size of the adherent cells and smaller than the size of the modified soluble cultivation support. Specifically, the pore size of the separation device may be larger than the longest diameter of the adherent cells and smaller than the shortest diameter of the modified soluble cultivation support. The pore size of the separation device may be, for example, in the range of 20 to 50 μm, 20 to 40 μm, or 20 to 30 μm. In the present disclosure, the hole diameter of a separation device means the diameter when the hole shape is circular, and means the length of the longest straight line among any straight lines passing through the center point of the hole in the cross section of the hole when the hole shape is other than circular.
[0055] The adherent cells separated and recovered from the denatured soluble culture carrier may be washed with a phosphate buffer solution or the like.
[0056] [Cell collection method] A cell recovery method according to an embodiment of the present disclosure includes preparing a cell suspension containing a cell complex comprising adherent cells and a soluble culture support larger than the size of the adherent cells, with the adherent cells disposed on the surface of the soluble culture support; subjecting the cell complex in the cell suspension to a denaturation treatment for denaturing at least a portion of the surface of the soluble culture support in order to detach the adherent cells from the surface of the soluble culture support; and separating and recovering the adherent cells in the cell suspension from the denatured soluble culture support larger than the size of the adherent cells based on the difference in size. According to this cell recovery method, the adherent cells arranged on the surface of the soluble culture carriers can be efficiently separated from the soluble culture carriers and recovered with high purity.
[0057] The cell recovery method may include preparing a cell suspension containing a cell complex comprising adherent cells and a soluble culture support larger than the size of the adherent cells, in which the adherent cells are arranged on the surface of the soluble culture support. The adhesive cells may be cultured in suspension on the surface of a soluble culture carrier. In this case, the cell recovery method of the present disclosure can be carried out by obtaining the cultured in suspension on the surface of a soluble culture carrier, or the cell recovery method of the present disclosure can be carried out after the suspension culture of the adhesive cells, which is usually carried out using a soluble culture carrier. The cell suspension may contain a cell complex in which the adhesive cells are arranged on the surface of a soluble culture carrier. The adhesive cells and the soluble culture carrier may be the same as those described above. The details of the cell complex in which the adhesive cells are arranged on the surface of a soluble culture carrier are as described above. In the cell suspension, the adherent cells may be located partially or entirely on the surface of the soluble culture support. The aqueous medium contained in the cell suspension may be a liquid such as a culture medium, physiological saline, or a phosphate buffer solution.
[0058] The cell recovery method can include subjecting the cell complex in the cell suspension to a denaturation treatment for denaturing at least a portion of the surface of the soluble cultivation support in order to detach the adherent cells from the surface of the soluble cultivation support. As for the denaturation treatment, the denaturation treatment in the culture production method of the present disclosure can be applied as is.
[0059] The cell recovery method can include separating and recovering the adhesive cells in the cell suspension from the denatured soluble culture carrier, which is larger than the size of the adhesive cells, based on the difference in size. The method for separating and recovering the cells can be directly applied to the denaturation treatment in the method for producing a culture product of the present disclosure. The adherent cells separated and recovered from the denatured soluble culture carrier may be washed with a phosphate buffer solution or the like.
[0060] The collected adherent cells may be in the form of a cell suspension in combination with a liquid such as a medium, physiological saline, or phosphate buffer. When collected as a cell suspension, the cell collection method may further include subjecting the cell suspension to a cryopreservation treatment. This allows for the production of a cryopreserved product of adherent cells with few impurities.
[0061] [Cell-containing composition] The cell-containing composition according to the embodiment of the present disclosure contains adherent cells, and the content of soluble cultivation support residues having a size of 20 μm or less is 1×10 cells 4 There can be 30 or less per piece. The cell-containing composition has a content of soluble culture carrier residues having a size of 20 μm or less, which is equal to or less than the size of adherent cells, of 1×10 cells. 4 Since the number of cells per cell is 30 or less, it is possible to provide adherent cells with few impurities and high purity. Here, the cell-containing composition may be any composition obtained by culturing adherent cells with a soluble cultivation carrier and then separating the soluble cultivation carrier from the soluble cultivation carrier, and examples of such compositions include a culture of adherent cells obtained by culturing adherent cells with a soluble cultivation carrier and then enzymatically treating the soluble cultivation carrier, a culture obtained by a culture production method according to one embodiment of the present disclosure, a cell suspension obtained by a cell recovery method according to another embodiment of the present disclosure, or frozen preserved products thereof.
[0062] The residue of the soluble culture carrier means a product obtained by a process for separating the soluble culture carrier from the adherent cells, and includes a dissolved residue (undissolved residue) of the soluble culture carrier after a dissolution process, a denatured residue of the soluble culture carrier after a denaturation process, etc. Examples of the dissolved residue include sugar chain fragments, polypeptide fragments, etc., which are generated when an enzyme is used as a surface denaturant. The cell-containing composition can contain the residue from the denaturation process of the soluble culture carrier together with the adherent cells.
[0063] The content of residues in the soluble cultivation carrier is 20 μm or less, preferably 1 μm to 20 μm, and is preferably 1×10 cells / mL. 4 The number per particle may be 30 or less, 25 or less, 20 or less, 15 or less, 10 or less, 8 or less, or 5 or less, and the number of residues of 1 μm or more may be 0 or 1 or more.
[0064] Here, in the cell-containing composition, 1×10 cells 4 The content of the residue of the soluble culture carrier having a size of 20 μm or less per cell can be calculated, for example, as follows. A part of the cell-containing composition is sampled, and then, using a microscope such as a phase contrast microscope, 5 fields of view are observed or images are taken at a magnification of, for example, 40 times. At this time, staining may be performed using a coloring agent known to react with the components of the soluble culture carrier. When the soluble culture carrier is composed of sugar, a dye capable of staining sugar can be used. Next, the number of cells observed in a predetermined area and the number of residues of the soluble culture carrier having a size of 20 μm or less, or a size of 1 μm to 20 μm, are counted, respectively.
[0065] The cell-containing composition can be confirmed as a composition obtained by the above-mentioned surface modification treatment of the soluble culture carrier by the following method. That is, the cell suspension after the modification treatment is passed through a mesh having a pore size of 20 μm or more, and the passed-through is confirmed by a phase contrast microscope at a magnification of 40 times or more. In the case of the cell-containing composition after the modification treatment, one or more residues of 1 μm or less can be confirmed per field of view by this observation. Another confirmation method may be a method of recovering the passed-through obtained and confirming the presence or absence of residue. The presence or absence of residue can be confirmed by, for example, a known confirmation method, such as a test using a color reaction or a dye.
[0066] The method for producing a culture according to an embodiment of the present disclosure and the method for recovering cells according to an embodiment of the present disclosure can produce a culture or recover cells easily and accurately without applying excessive stress to the adherent cells, and therefore the obtained culture and adherent cells can exhibit high survival rates. The culture obtained by the culture production method according to an embodiment of the present disclosure, the cells recovered by the cell recovery method according to an embodiment of the present disclosure, and the cell-containing composition according to an embodiment of the present disclosure are low in impurities other than cells, such as soluble culture carriers, dissolved residues of soluble culture carriers, etc. Therefore, the culture obtained by the culture production method according to an embodiment of the present disclosure, the cells recovered by the cell recovery method according to an embodiment of the present disclosure, and the cell-containing composition according to an embodiment of the present disclosure can be suitably used as cells or cell-containing compositions for cell preparations.
[0067] [kit] The kit according to one embodiment of the present disclosure comprises a soluble Culture carrier and instructions for use. The instructions include a method for producing a culture according to an embodiment of the present disclosure or a method for recovering cells according to an embodiment of the present disclosure, Culture carrier It is preferable that the instruction manual states that the soluble Culture carrier Examples of the soluble ... Culture carrier It may be only other soluble Culture carrier or a combination of these.
[0068] The kit according to another embodiment of the present disclosure comprises a soluble Culture carrier and instructions for use. The instructions preferably state that the surface denaturant is used in the culture production method according to an embodiment of the present disclosure or the cell recovery method according to an embodiment of the present disclosure. The surface denaturant described in the instructions may be only the surface denaturant described in the culture production method according to an embodiment of the present disclosure or the cell recovery method according to an embodiment of the present disclosure, or may be other surface denaturants, or may be a combination of these.
[0069] In accordance with yet another embodiment of the present disclosure, the kit comprises a soluble Culture carrier and soluble Culture carrier The method includes a surface denaturing agent for denaturing a soluble ... Culture carrier The surface denaturant described in the instruction manual may be only the surface denaturant described in the method for producing a culture according to an embodiment of the present disclosure or the method for recovering cells according to an embodiment of the present disclosure, or may be other surface denaturants, or may be a combination of these. Culture carrier Examples of the soluble ... Culture carrier It may be only other soluble Culture carrier or a combination of these.
[0070] According to one embodiment of the kit of the present disclosure, the soluble Culture carrier , surface modifiers, or combinations thereof, are provided with instructions for use describing one or more of these embodiments, Culture carrier , surface modifiers, or combinations thereof can be quickly and easily realized.
[0071] In each of the above-mentioned kits, the details of the culture production method according to one embodiment of the present disclosure or the cell recovery method according to one embodiment of the present disclosure are as described above. Culture carrier The details of the surface modifying agent are also as described above. Each of the above kits may further include a medium, a physiological saline solution, a phosphate buffer solution, a separation device such as a filter, a container, or a combination of two or more of these.
[0072] The instructions included in each of the above-mentioned kits include any medium capable of conveying the contents of the instructions to the user. The instructions may be, for example, a package insert in which the instructions are printed on paper or other sheet-like material, or may be a package insert in which the instructions are printed on packaging material such as a packaging container, packaging paper, or packaging bag, or may be a computer-readable medium in which the instructions are recorded as data on a recording medium such as an optical disk such as a CD, DVD, or Blu-ray disk, a flash memory, or a magnetic disk. Alternatively, the instructions may be an address of an internet site providing the instructions, and the address of the internet site may be provided by printing or recording on a package insert, packaging material, data recording medium, or the like. The instructions may be provided in a form that is soluble in water. Culture carrier Alternatively, one instruction manual may be provided for each package of surface modifier, and the soluble Culture carrier Alternatively, one or more instructions for use may be provided for multiple packages of the surface modifying agent. EXAMPLES
[0073] The present invention will be described in more detail below with reference to examples. However, the present invention is not limited to these examples as long as it does not deviate from the technical concept of the present invention.
[0074] [Examples 1 to 3] (1)Cell culture Cells were cultured using a 6-well plate. Specifically, human mesenchymal stem cells (MSCs) were cultured at a volume of 2.0 mL / well. The medium used was 1.0 L of αMEM supplemented with 10% (v / v) FBS (fetal bovine serum). Microcarriers, which are culture supports, were added to the medium together with the cells, and the cells were cultured with shaking in a CO2 incubator maintained at a temperature of 37°C and a CO2 concentration of 5%. After the start of culture, a cell complex was observed in which the cells were arranged on the surface of the microcarrier. Cytodex 1 (crosslinked dextran having N,N-diethylaminoethyl groups, D50: 180 μm) (Cytiva) was used as the microcarrier. The minimum diameter of Cytodex 1 was confirmed to be over 50 μm. The seeding density of the cells was 3000 cells / mL, and the initial amount of the microcarriers was 0.001 g / mL (5 cm 2 / mL).
[0075] (2) Cell collection A cell suspension containing cells and microcarriers as cell complexes was collected from a 6-well plate containing cells cultured for one week, and washed twice with DPBS (Dulbecco's phosphate buffered solution). After washing, the supernatant was aspirated, and then 1 mL / well of a reagent prepared with dextranase (Sigma) and trypsin-EDTA solution (0.25 w / v%, 0.02 w / v%, Sigma) at 37°C was added, seeded in each well, and left to stand. The final concentrations of dextranase were 0.1 v / v%, 0.01 v / v%, and 0.001 v / v%, respectively, relative to the total volume of the cell suspension in the well, and the final concentration of trypsin was 0.2 w / v%. The pH of the medium at this time was 7.1 to 7.2. After 10 minutes, the cells were observed under a phase contrast microscope (observation result 1). After the denaturation treatment, each cell suspension was pipetted 10 times and then observed under a phase contrast microscope (observation result 2). Then, the cell suspension was passed through a mesh with a pore size of 20 μm (cell strainer, Corning Inc.) to recover the cells, and the cell recovery rate and cell viability were evaluated using a NucleoCounter (registered trademark) NC-200, Chemometec Inc. The results are shown in Table 1. The cell recovery rate is the ratio of the number of cells recovered to the number of cells after culture. The cell viability rate is the ratio of the number of viable cells to the number of cells recovered.
[0076] [Comparative Example 1] In Example 1(2), after washing the cell suspension, the supernatant was aspirated, and then a reagent prepared only with 37°C trypsin-EDTA solution (0.25 w / v%, 0.02 w / v%) (final trypsin concentration: 0.25 w / v%) was added to 1 mL / well, and the treatment was carried out in the same manner as in Example 1. Thereafter, the cells were recovered and the cell recovery rate and cell viability were evaluated. The results are shown in Table 1.
[0077] [Comparative Example 2] In Example 1 (2), the cells were collected and washed with DPBS, and then 500 U / mg dextranase (product number: D0443-250ML, Sigma) was added to each well to a concentration of 10 mg / 50 mL per 50 mL of microcarrier according to the description in the microcarrier product protocol, and the microcarrier was dissolved at 37°C and pH 6.0 for 20 minutes. Thereafter, the cells were collected in the same manner as in Example 1, and the cell recovery rate and cell viability were evaluated. The results are shown in Table 1. [Comparative Example 3] Treatment was carried out in the same manner as in Example 1 (2), except that the concentration of dextranase was 1% (v / v) and the reaction time was 20 minutes. Thereafter, cells were recovered in the same manner as in Example 1, and the cell recovery rate and cell viability were evaluated. The results are shown in Table 1.
[0078] After the denaturation treatment, the cell suspension was observed with a phase-contrast microscope (CKX53, Olympus Corporation) and the results (observation result 1 above) were evaluated according to the following criteria. The results are shown in Table 1. A: Microcarriers and cells are observed. Microcarriers smaller than the size of cells are 1×10 cells. 4 Fewer than 30 per unit, or none observed. B: Cells are observed. The particulate microcarriers have been dissolved and are no longer visible, but numerous microcarrier-derived residues that are the same size as or smaller than cells are observed.
[0079] [Table 1]
[0080] In Figs. 1 and 2, The above For the examples and comparative examples, photographic images of cell suspensions observed under a phase contrast microscope after denaturation treatment are shown. Fig. 1 is a photographic image of the above-mentioned Observation Result 1 at a magnification of 10 times, where the upper left of Fig. 1 is Example 1, the upper right of Fig. 1 is Example 2, the lower left of Fig. 1 is Example 3, and the lower right of Fig. 1 is Comparative Example 1. Fig. 2 is a photographic image of the above-mentioned Observation Result 2 at a magnification of 40 times, which is Comparative Example 3.
[0081] In Examples 1 to 3, as shown in Table 1, the cell recovery rate was 15% or more, and the cell survival rate was 90% or more. In addition, as shown in FIG. 1, when the cell suspension was observed after the denaturation treatment, the microcarriers were present together with the cells without being completely dissolved. Observation was performed using a phase contrast microscope, and the minimum diameter of the microcarriers was confirmed over five fields of view using a measure attached to the microscope. All of them exceeded 50 μm, and when the average of the minimum diameters was compared with the size of the microcarriers before the denaturation treatment, all of them were 90% or more. On the other hand, an attempt was made to confirm residues such as undissolved microcarriers using a similar method, but no residues such as undissolved microcarriers of the same size or smaller than the size of the cells were confirmed (see FIG. 1). For this reason, by using a mesh to collect the cells, it was possible to easily separate the microcarriers and collect only the cells with high accuracy.
[0082] On the other hand, in Comparative Example 1, as shown in Table 1, the cell recovery rate was low, less than 10%. In addition, as shown in FIG. 1, when the cell suspension was observed after the denaturation treatment, the microcarriers were present in the cell suspension together with the cells without being completely dissolved. When the number of residues was confirmed by the same method as above, no residues such as undissolved microcarriers that were equal to or smaller than the size of the cells were found. Therefore, by using a mesh to recover the cells, the cells could be easily separated from the microcarriers, but many adhesive cells were present, caught on the surface of the microcarriers left on the mesh. This shows that the cell release agent alone was insufficient to detach the cells from the microcarriers.
[0083] In Comparative Examples 2 and 3, when the cell suspension was observed after the denaturation treatment, the microcarriers were almost completely dissolved, and instead, many cell clumps composed of multiple cells were observed. When the cell suspension was checked after pipetting, the cell clumps observed before pipetting were dispersed as single cells, but together with the cells, a large amount of microcarrier residue was present as fine particles having a size of 20 μm or less, in other words, fine objects smaller than the size of a cell (Comparative Example 3: see FIG. 2. The same applies to Comparative Example 2. Not shown). The three arrows in FIG. 2 indicate residues smaller than cells, that is, undissolved residues. Furthermore, in Comparative Examples 2 and 3, as shown in Table 1, the cell recovery rate and cell survival rate were high, and this high cell recovery rate was due to the entire microcarrier being dissolved. However, as mentioned above, the cell suspension contains a large amount of microcarrier residue of 20 μm or less, and even if an attempt is made to collect only the cells using a mesh or the like, a large amount of residue gets mixed in, making it impossible to accurately separate only the cells.
[0084] The disclosure of this application relates to the subject matter described in Japanese Patent Application No. 2021-060494, filed on March 31, 2021, the entire disclosure of which is incorporated herein by reference. It should be noted that, in addition to those already mentioned, various modifications and changes may be made to the above-described embodiments without departing from the novel and advantageous features of the present disclosure. Accordingly, all such modifications and changes are intended to be included within the scope of the appended claims.
Claims
1. Contacting the adherent cells with a soluble cultivation support that is larger than the size of the adherent cells, and arranging the adherent cells on the surface of the soluble cultivation support; Cultivating the adherent cells arranged on the surface of the soluble cultivation support in a suspension culture medium; performing a modification treatment on the soluble cultivation support in the suspension culture, the modification treatment being selected according to the type of the soluble cultivation support and modifying at least a part of the surface of the soluble cultivation support; A method for producing a culture, comprising: after the denaturation treatment, separating and recovering the adherent cells from a denatured soluble cultivation support that is larger than the size of the adherent cells based on the difference in size.
2. The method of claim 1 , wherein the soluble cultivation support comprises a polysaccharide, a protein, or a combination thereof.
3. The method for producing a culture according to claim 1 or 2, wherein the soluble culture support comprises at least one selected from the group consisting of dextran, cellulose, collagen, gelatin, polygalacturonic acid, alginic acid, and derivatives thereof.
4. The method for producing a culture according to claim 1 , wherein the soluble cultivation support is porous.
5. The method for producing a culture according to claim 1 , wherein the denaturation treatment comprises denaturing the soluble cultivation support with a surface denaturing agent.
6. The method for producing a culture according to claim 1 , wherein the adherent cells and the modified soluble cultivation support are separated using a separation device.
7. The method for producing a culture according to claim 6, wherein the separation device has a pore size of 20 to 50 μm.
8. The method for producing a culture according to any one of claims 1 to 7, wherein the modified soluble cultivation support has a minimum diameter exceeding 50 µm.
9. The method for producing a culture according to claim 1 , wherein the denaturation treatment is carried out using a surface denaturing agent, and the surface denaturing agent is a dissolving agent or a decomposing agent for a soluble cultivation support.
10. preparing a cell suspension containing adherent cells and a soluble culture support larger than the size of the adherent cells, the cell suspension including a cell complex in which the adherent cells are arranged on the surface of the soluble culture support; subjecting the cell complex in the cell suspension to a denaturing treatment selected according to the type of the soluble cultivation support and which denatures at least a part of the surface of the soluble cultivation support; A cell recovery method comprising: separating and recovering the adherent cells in the cell suspension from a modified soluble culture support that is larger than the size of the adherent cells, based on the difference in size.
11. A kit comprising a soluble cultivation support and an instruction manual describing the use of the soluble cultivation support in the method for producing a culture product described in any one of claims 1 to 9 or the cell recovery method described in claim 10.
12. A kit comprising a surface modifying agent for modifying a soluble cultivation support and instructions for use describing the use of the surface modifying agent in a culture production method described in any one of claims 1 to 9 or a cell recovery method described in claim 10.
Citation Information
Patent Citations
Culture of attachment cell
JP1990171183A
Method of recovering cells from scaffold material, and polysaccharide scaffold material for cell culture
JP2018068154A
Culture medium composition, and method for culturing cell or tissue using said composition
WO2014017513A1
Culture medium composition
WO2015111686A1
